• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The cholera challenge: How should the world respond?

作者信息

Al-Tawfiq Jaffar A, Chopra Hitesh, Dhama Kuldeep, Sah Ranjit, Schlagenhauf Patricia, Memish Ziad A

机构信息

Infectious Disease Unit, Specialty Internal Medicine, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.

Division of Infectious Diseases, Indiana University School of Medicine, Indianapolis, IN, USA.

出版信息

New Microbes New Infect. 2022 Dec 23;51:101077. doi: 10.1016/j.nmni.2022.101077. eCollection 2023 Jan.

DOI:10.1016/j.nmni.2022.101077
PMID:36654941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9841269/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6497/9841269/f35933224580/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6497/9841269/f35933224580/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6497/9841269/f35933224580/gr1.jpg

相似文献

1
The cholera challenge: How should the world respond?霍乱挑战：世界应如何应对？
New Microbes New Infect. 2022 Dec 23;51:101077. doi: 10.1016/j.nmni.2022.101077. eCollection 2023 Jan.
2
Is cholera disease associated with poverty?霍乱病与贫困有关吗？
J Infect Dev Ctries. 2009 Jul 1;3(6):408-11. doi: 10.3855/jidc.410.
3
Secondary Vibrio cholerae-specific cellular antibody responses following wild-type homologous challenge in people vaccinated with CVD 103-HgR live oral cholera vaccine: changes with time and lack of correlation with protection.接种CVD 103-HgR口服霍乱活疫苗的人群在接受野生型同源菌株攻击后的霍乱弧菌特异性细胞抗体反应：随时间的变化及与保护作用的无关性
Infect Immun. 1993 Feb;61(2):729-33. doi: 10.1128/iai.61.2.729-733.1993.
4
A review of the current status of enteric vaccines.肠道疫苗现状综述
P N G Med J. 1995 Dec;38(4):325-31.
5
Meeting cholera's challenge to Haiti and the world: a joint statement on cholera prevention and care.应对霍乱对海地及全球的挑战：关于霍乱预防与护理的联合声明
PLoS Negl Trop Dis. 2011;5(5):e1145. doi: 10.1371/journal.pntd.0001145. Epub 2011 May 31.
6
Enterotoxin-induced fluid accumulation during experimental salmonellosis and cholera: involvement of prostaglandin synthesis by intestinal cells.实验性沙门氏菌病和霍乱期间肠毒素诱导的体液积聚：肠道细胞前列腺素合成的参与
Toxicon. 1985;23(1):157-72. doi: 10.1016/0041-0101(85)90118-7.
7
A successful response to an outbreak of cholera in Afghanistan.对阿富汗霍乱疫情的成功应对。
Trop Doct. 2008 Jan;38(1):17-20. doi: 10.1258/td.2006.006336.
8
[Impressions of a World Health Organization course on cholera bacteriology and the most recent views on cholera vaccine; 2-11 October 1965 at Teheran].[关于世界卫生组织霍乱细菌学课程及霍乱疫苗最新观点的印象；1965年10月2日至11日于德黑兰]
Turk Hij Tecr Biyol Derg (1961). 1965;25(2):206-25.
9
A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mice.一种含有霍乱弧菌O1稻叶型O特异性多糖（OSP）和破伤风毒素重链重组片段（OSP:rTTHc）的霍乱结合疫苗可诱导针对OSP的血清、记忆和固有层反应，并对小鼠具有保护作用。
PLoS Negl Trop Dis. 2015 Jul 8;9(7):e0003881. doi: 10.1371/journal.pntd.0003881. eCollection 2015.
10
Evaluation in mice of a conjugate vaccine for cholera made from Vibrio cholerae O1 (Ogawa) O-specific polysaccharide.霍乱弧菌 O1（稻叶型）O 特异性多糖结合疫苗在小鼠体内的评价。
PLoS Negl Trop Dis. 2014 Feb 6;8(2):e2683. doi: 10.1371/journal.pntd.0002683. eCollection 2014 Feb.

引用本文的文献

1
Case report: Characterization and bioinformatics analysis of non-O1/O139 strain isolated from a choledochoduodenal fistula patient with septicemia.病例报告：从一名患有败血症的胆总管十二指肠瘘患者中分离出的非O1/O139菌株的特征及生物信息学分析。
Front Med (Lausanne). 2024 Oct 3;11:1458143. doi: 10.3389/fmed.2024.1458143. eCollection 2024.
2
Mathematical modeling of cholera dynamics with intrinsic growth considering constant interventions.考虑恒定干预的具有固有增长率的霍乱动力学的数学建模。
Sci Rep. 2024 Feb 26;14(1):4616. doi: 10.1038/s41598-024-55240-0.
3
Whole Genome Analysis of a Non-O1, Non-O139 Detected from Human Blood in China.

本文引用的文献

1
Addressing the shortage of cholera vaccines.应对霍乱疫苗短缺问题。
Lancet Infect Dis. 2022 Dec;22(12):1674-1675. doi: 10.1016/S1473-3099(22)00752-6.
2
Comparative analysis of isolates from Ghana reveals variations in genome architecture and adaptation of outbreak and environmental strains.对来自加纳的分离株进行的比较分析揭示了基因组结构的差异以及暴发菌株和环境菌株的适应性。
Front Microbiol. 2022 Oct 13;13:998182. doi: 10.3389/fmicb.2022.998182. eCollection 2022.
3
Cholera.霍乱。
在中国从人血液中检测到的一株非O1、非O139型霍乱弧菌的全基因组分析
Infect Drug Resist. 2023 Aug 21;16:5453-5461. doi: 10.2147/IDR.S420095. eCollection 2023.
4
Recent surge in cholera outbreaks globally during the COVID-19 pandemic era: a potential threat to the African continent and salient counteracting strategies.2019冠状病毒病大流行时代全球霍乱疫情近期激增：对非洲大陆的潜在威胁及显著应对策略
Int J Surg. 2023 Mar 1;109(3):631-633. doi: 10.1097/JS9.0000000000000222.
Lancet. 2022 Apr 9;399(10333):1429-1440. doi: 10.1016/S0140-6736(22)00330-0.
4
Cholera dynamics: lessons from an epidemic.霍乱动力学：疫情带来的启示。
J Med Microbiol. 2021 Feb;70(2). doi: 10.1099/jmm.0.001298.
5
Cholera, the Current Status of Cholera Vaccines and Recommendations for Travellers.霍乱、霍乱疫苗的现状及对旅行者的建议
Vaccines (Basel). 2020 Oct 14;8(4):606. doi: 10.3390/vaccines8040606.
6
Cholera in travellers: a systematic review.旅行者中的霍乱：系统评价。
J Travel Med. 2019 Dec 23;26(8). doi: 10.1093/jtm/taz085.
7
Lack of Vibrio cholerae among French pilgrims during the 2017 and 2018 Hajj.2017年和2018年朝觐期间法国朝圣者中霍乱弧菌的缺失情况。
Travel Med Infect Dis. 2020 Jul-Aug;36:101506. doi: 10.1016/j.tmaid.2019.101506. Epub 2019 Oct 29.
8
The Hajj 2019 Vaccine Requirements and Possible New Challenges.2019 年朝觐疫苗接种要求和可能出现的新挑战。
J Epidemiol Glob Health. 2019 Sep;9(3):147-152. doi: 10.2991/jegh.k.190705.001.
9
The challenges of cholera at the 2017 Hajj pilgrimage.2017年朝觐期间霍乱面临的挑战。
Lancet Infect Dis. 2017 Sep;17(9):895-897. doi: 10.1016/S1473-3099(17)30454-1. Epub 2017 Aug 10.
10
Assessing different measures of population-level vaccine protection using a case-control study.使用病例对照研究评估人群层面疫苗保护的不同指标。
Vaccine. 2015 Nov 27;33(48):6878-83. doi: 10.1016/j.vaccine.2015.07.045. Epub 2015 Sep 9.